LitAlert ~~ GeneLit.com

    • Rare coding variants in DNA damage repair genes associated with timing of natural menopause.
    • Ward LD, Parker MM, Deaton AM, Tu HC, Flynn-Carroll AO, Hinkle GNioi P.
    • HGG Adv. 2021 Dec 21 [eCollection 2022 Apr 14];3(2):100079. doi: 10.1016/j.xhgg.2021.100079.
    • Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
    • Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, Parsons MT, Mizukami K, Sekine Y, Hirata M, Kamatani Y, Endo M, Inai C, Takata S, Ito H, Kohno T, Matsuda K, Nakamura S, Sugano K, Yoshida T, Nakagawa H, Matsuo K, Murakami Y, Spurdle AB, Kubo M.
    • JAMA Oncol. 2022 Apr 14. doi: 10.1001/jamaoncol.2022.0476. Epub ahead of print.
    • Editorial: Familial Cancer in China: From Detection to Screening and Management.
    • Chen T, Yuan Y.
    • Front Oncol. 2022 Apr 13;12:916814. doi: 10.3389/fonc.2022.916814.
    • Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.
    • Park SS, Uzelac A, Kotsopoulos J.
    • Hered Cancer Clin Pract. 2022 Apr 13;20(1):14. doi: 10.1186/s13053-022-00223-3.
    • Appropriate Selection of PARP Inhibitors in Ovarian Cancer.
    • Smith M, Pothuri B.
    • Curr Treat Options Oncol. 2022 Apr 12. doi: 10.1007/s11864-022-00938-4. Epub ahead of print.
    • Review
    • Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals.
    • Levink IJM, Klatte DCF, Hanna-Sawires RG, Vreeker GCM, Ibrahim IS, van der Burgt YEM, Overbeek KA, Koopmann BDM, Cahen DL, Fuhler GM, Wuhrer M, Bonsing BA, Tollenaar RAEM, Vleggaar FP, Vasen HFA, van Leerdam ME, Bruno MJ, Mesker WE.
    • Pancreatology. 2022 Apr 4:S1424-3903(22)00135-1. doi: 10.1016/j.pan.2022.03.021. Epub ahead of print.